A broad majority in the Danish Parliament has reached an agreement on multi-year billion-dollar investments in Danish ...

Japanese drug major Takeda Friday announced new interim data from the Phase Ib, open-label, proof-of-concept study of ...

The Association of the British Pharmaceutical Industry has urged the UK government to use the upcoming Budget to address what ...

Positive full results from the NATRON Phase III trial showed AstraZeneca’s Fasenra (benralizumab) demonstrated a ...

US biotech Gilead Sciences (Nasdaq: GILD) has suffered another disappointment for its cancer therapy Trodelvy (sacituzumab ...

Greece’s pharmaceutical industry is now contributing more to national drug costs than the state itself, according to the ...

In what is being termed a landmark decision, the Indian Patent Office has annulled Novartis’ patent for its heart failure drug Vymada, internationally known as Entresto (sacubitril/valsartan), citing ...

Research news last week featured US CRIPR genome-editing company Caribou Biosciences announcing positive early data on its ...

The UK Medicines and Healthcare products Regulatory Agency (MHRA) has approved Pfizer’s extension to the licence of the ...

The last week or so has seen an escalation of the bidding war for US obesity-focused Metsera, with counter bids and law suits ...

Healthcare giant Johnson & Johnson has announced that the US Food and Drug Administration (FDA) has approved Caplyta ...

Biopharma company Pelthos Therapeutics has acquired the US commercialization rights to Xepi (ozenoxacin) Cream, 1%, from ...